Lung Cancer in South Carolina...

  • will be diagnosed in approximately 3,900 SC citizens in 2011.
  • will tragically take the lives of approximately 2,910 South Carolinians in 2011, as well.
  • is grossly underfunded, unidentified, and stigmatized.
  • is ravaging and must be cured.

Saturday, June 13, 2009

ABC News reports: Senate Votes for FDA to Regulate Tobacco

Years in the Making, Senate Votes to Give FDA Power to Regulate Tobacco

Times have changed now that even tobacco states have smoking bans. Today, after two weeks of wrangling and a decade of considering the change, the U.S. Senate endorsed increased regulation of tobacco.

Senators voted 79-17 to regulate tobacco in the same way the government regulates everything else you put in your body -- from Froot Loops to aspirin.

At Campaign for Tobacco-Free Kids, organization president Matthew L. Myers called the vote "a truly historic victory" and "the strongest action Congress has ever taken to reduce tobacco use."

"Forty-five years after the first U.S. Surgeon General's report linking cigarette smoking to lung cancer, the most deadly product sold in America will no longer be the least-regulated product sold in America," Myers said in a statement.

The bill would give the federal government the power to regulate cigarette ingredients, to ban the marketing of "light cigarettes" and to require graphic warning labels.

Read more.

Tuesday, June 9, 2009

The New York Times: George MacPherson, Theater Producer, Dies at 78

George MacPherson, a theater producer who helped bring down the curtain on bus-and-truck road shows and usher in the big-box-office age of polished national touring companies, died on Wednesday in Orangeburg, S.C., where he lived. He was 78.

The cause was lung cancer, said his daughter, Morag.

Mr. MacPherson, who got his first taste of show business glamour as a veterinarian with the Ringling Brothers and Barnum & Bailey Circus, helped theater producers maximize returns on their shows by sending out touring companies with high production values and first-rate performers to markets beyond the big cities.

This approach, restructured in the early 1980s at American Theater Productions, where he was executive director, led to increased subscription sales and a boom for the tour business, which nearly doubled its gross revenues from 1988 to 1991.

“In those days, touring was pretty rudimentary,” said Miles Wilkin, the chief executive of the tour producer Broadway Across America. “George was adept at working with New York producers, acquiring shows and then realizing their full potential on the road.”

Read more.




Sunday, June 7, 2009

Men with cancer bond in support group

It was about five years ago when Walt Beigegrain flopped onto his bed, crossed his arms and felt a lump on his chest.

“What is that?” he wondered. About five weeks later, after summoning the courage to seek help, his doctor initially confirmed that yes, he had a lump, but it couldn’t be breast cancer, because men don’t get breast cancer. Another physician echoed those same thoughts.

However, tests showed a different story, and Beigegrain’s breast cancer was in Stage II, which is a treatable phase.

“I figured, ‘So what, I have breast cancer,’ ” he said. “I can deal with that.”

Beigegrain did deal with that. He had the tumor removed in surgery. He now can talk openly about his breast cancer, but he knows other men suffer alone after being diagnosed with breast cancer or any other form of the disease.

They needn’t.

For the past few years, a local all-male group, Men Against Cancer Helping Others, or MACHO, has been attracting more members than any of the numerous cancer-support groups for women organized through St. Mary’s Hospital, said Debra Hesse, coordinator of cancer survivor programs for St. Mary’s Cancer Center.

At a recent meeting, men gathered around tables at a coffee shop near the hospital and greeted one another with strong handshakes and pats to the back.

Dressed in blue jeans, button-up shirts or T-shirts and sneakers or hiking boots, the men stick to an agenda that usually includes a guest speaker and review of a book related to cancer.

But outside of those general guidelines, men said they’ve grown to feel free to be themselves, and conversations can include guys asking each other advice about their battles with similar forms of cancer or tips on how to be a better husband to a spouse with the disease.

But the reason the meetings work, they said, is because a group dynamic helps ease the stigma men feel about getting cancer.

Also the focus is neither a “prayer session, or a pity party,” they said.

“The male instinct is, if there’s a problem, I need to fix it,” said Michael Appel, the lead pharmacist who helps run meetings.

Read more.

Science Daily reports: Stem Cell Protein Offers A New Cancer Target

A protein abundant in embryonic stem cells is now shown to be important in cancer, and offers a possible new target for drug development, report researchers from the Stem Cell Program at Children's Hospital Boston.

Last year, George Daley, MD, PhD, and graduate student Srinivas Viswanathan, in collaboration with Richard Gregory, PhD, also of the Stem Cell Program at Children's, showed that the protein LIN28 regulates an important group of tumor-suppressing microRNAs known as let-7. Increasing LIN28 production in a cell prevented let-7 from maturing, making the cell more immature and stem-like. Since these qualities also make a cell more cancerous, and because low levels of mature let-7 have been associated with breast and lung cancer, the discovery suggested that LIN28 might be oncogenic.

Now, publishing Advance Online in Nature Genetics on May 31, Daley, Viswanathan and colleagues show directly that LIN28 can transform cells to a cancerous state, and that it is abundant in a variety of advanced human cancers, particularly liver cancer, ovarian cancer, chronic myeloid leukemia, germ cell tumors and Wilm's tumor (a childhood kidney cancer). They believe that overall, LIN28 and a related protein, LIN28B, may be involved in some 15 percent of human cancers. By blocking or suppressing LIN28, it might be possible to revive the let-7 family's natural tumor-suppressing action.

"Linking this protein to advanced cancer is a very exciting new result," says Daley, Director of Stem Cell Transplantation at Children's, and also affiliated with Children's Division of Hematology/Oncology, the Dana-Farber Cancer Institute and the Harvard Stem Cell Institute. "It gives us a new target to attack, especially in the most resistant and hard-to-treat cases."

Read more.

Science Daily reports: Brain Irradiation In Lung Cancer

A national Radiation Therapy Oncology Group (RTOG) study led by a Medical College of Wisconsin Cancer Center physician at Froedtert Hospital in Milwaukee has found that a course of radiation therapy to the brain after treatment for locally advanced non-small cell lung cancer reduced the risk of metastases to the brain within the first year after treatment.

"With improved treatments for non-small cell lung cancer, patients are living longer and we are seeing more brain metastases," says study author Elizabeth Gore, M.D. "This study compared the efficacy of prophylactic (preventive) cranial irradiation (PCI) vs. observation in these patients, and found that those not receiving cranial irradiation were two and one-half times more likely to develop brain metastasis than those who did."

Read more.

Friday, June 5, 2009

Looking for volunteers in the Midlands Area to help me organize a Free To Breathe 5K Lung Cancer Awareness Walk...






I'm looking for fellow volunteers/advocates that may be interested in helping me organize a Free To Breathe Lung Cancer 5K Awareness Walk in Columbia. Possibly Saturday, November 14, 2009 at the Riverfront Park in downtown Columbia. (November is Lung Cancer Awareness Month)

Everyday is still a struggle, since losing my mother in 2007. My faith, family, and close friends keep me going. My dream is to one day bring a state chapter of the National Lung Cancer Partnership here to South Carolina, to support survivors and caregivers, as well as, raise money for much needed research.

The National Lung Cancer Partnership is a group of leading doctors, researchers, patient advocates, and lung cancer survivors who are working together to improve treatments for lung cancer patients. They raise research dollars through their Free To Breathe campaign, a 5K fundraising awareness walk.

You can find more information here:



Our neighboring state of North Carolina started the first state chapter in 2006 and have many events planned for this year. I'd love to one day do the same here.

Please consider helping me.

While I Breathe, I Hope...for a CURE for Lung Cancer!

Angie B. Derrick

You can send me a message here, or at scagainstlungcancer@gmail.com


Thursday, June 4, 2009

Lung Cancer Deaths Rise With Hormone Replacement Therapy

Doctors once thought that hormone therapy, or HRT, could protect women from chronic diseases, especially heart disease. However, a new study by U.S researchers released on Saturday indicated that the use of hormone-replacement therapy by menopausal women increases their risk of death from lung cancer by 60 percent after five years.

The trial studied the use of Wyeth's combined estrogen/progestin hormone-replacement therapy, Prempro. Dr. Rowan Chlebowski of Harbor-UCLA Medical Center in Los Angeles led the analysis and presented results at a meeting of the American Society of Clinical Oncology in Florida.

The study examined non-small-cell lung cancer, by far the most common type. While the study found no big difference in the number of lung cancers that developed in hormone users after five years on the pills and more than two years later, lung cancer proved fatal in 46 percent of hormone users who developed it versus 27 percent of those given placebos.

The study gave 16,608 women either Prempro or placebos. It was stopped in 2002 when researchers saw more breast cancers in those on Prempro, but researchers continue to follow women in the study.

Lung cancer is the world's top cancer killer. In the U.S alone, there were more than 215,000 new cases and nearly 162,000 deaths from it last year.

Transgene sees cancer deal this summer

Transgene expects to strike a worldwide partnership agreement this summer for lung cancer vaccine TG4010, a possible blockbuster, that could speed up the French biotech's plans to become a pharmaceutical group.

Next to advanced non-small cell lung cancer, TG4010 could work on several other cancer types like prostate and breast cancer, possibly making it a rival to Roche's Avastin.

Read more.

Newsday.com reports: Bill to regulate tobacco products a sharp departure for industry-friendly Congress

In the half-century since the surgeon general issued his culture-changing report linking smoking to lung cancer, the tobacco industry has had little trouble defeating efforts to regulate cigarettes and other products. That could change this year.

The Senate is debating legislation that would give the Food and Drug Administration authority to control ingredients going into tobacco products, restrict marketing and ads aimed at young people, and ban words such as "light" or "low tar" that may mislead people about the health risks of smoking.

The legislation, said Matthew Myers, president of Campaign for Tobacco-Free Kids, is "by far the strongest bill to reduce tobacco use that this nation has ever seriously considered."

Myers and other supporters, such as the American Heart Association and the American Lung Association, say the stars may finally be aligned for decisive action on the tobacco issue. The House passed a similar bill by a wide margin and President Barack Obama supports it. It also commands a majority in the Senate, although tobacco-state senators say they won't give up without a filibuster fight.

Read more.

From Japan: 1 in 8 with lung cancer show asbestos exposure, study finds

Pleural plaques, or a thickening of lung membranes due to asbestos exposure, were found in one in eight lung cancer patients, according to medical research papers jointly released Monday by 12 medical institutions in Japan.

The research team said the number of people who died from asbestos-related might amount to several thousand people a year.

About 60,000 people die from lung cancer each year in the nation.

In fiscal 2007, only 660 people were recognized as suffering from asbestos-related lung cancer and thus eligible for government aid, indicating that many lung cancer patients are excluded from the aid as the exposure has not been confirmed as the cause of their diseases.

Between 2006 and 2007, the 12 medical institutions in six prefectures, including Tokyo, Hokkaido and Aichi, examined 471 patients, aged 26 to 94 who were diagnosed with nonmetastatic lung cancer, to check if they had developed pleural plaques.

The 12 institutions belong to the Japan Federation of Democratic Medical Institutions.
The research team discovered pleural plaques in 28 patients, or 5.9 percent, through chest X-rays, and in 58 patients, or 12.3 percent, through high-resolution .

Pleural plaques were detected through the CT scan mainly in people engaged in professions involving repeated asbestos exposure, with 14 out of 35 patients working in the construction industry and six out of 23 in the metal manufacturing and processing industry.

Read more.

Wednesday, June 3, 2009

WYFF4 of Greenville: Keisha Kirkland Extends Thanks For Support


On the last day of her treatment for stage three lung cancer, WYFF News 4 Weather Anchor Keisha Kirkland extended a video thank you to all viewers for the messages and calls of support.

Kirkland was diagnosed in November and shortly afterward underwent surgery to remove the upper right lung mass.

Go here to view what Keisha has to say in her own words.

An opinion from LA Times: Tobacco regulations are no regulations at all

A proposal to put cigarettes under FDA supervision is so limited that it's really a smoke screen for Big Tobacco.

This week, the U.S. Senate is considering legislation that would, for the first time, give the Food and Drug Administration regulatory authority over tobacco products. Numerous anti-smoking and health groups support the legislation. So does this mean Congress is finally on the verge of stepping up to take on Big Tobacco?

Hardly. The bill in question was crafted, in part, by the nation's leading cigarette company, Philip Morris, as part of a deal worked out between the tobacco giant and an anti-smoking group -- the Campaign for Tobacco-Free Kids. The health groups supporting the legislation have been seduced by the few concessions that Philip Morris dangled before them and have lost sight of the long-term damage that this bill will do to the public's health.

The legislation would do a few good things, including requiring stronger warning labels on cigarette packages and limiting cigarette advertising directed at youths. But the bill's fine print contains numerous loopholes inserted to appease Philip Morris. In the end, it ensures that federal regulation of tobacco products will remain more about politics than about science.

Read more.


USA Today reports: Using CT scans to screen for lung cancer may carry risks

Lung cancer screenings may carry hidden dangers, researchers announced Saturday at the American Society of Clinical Oncology meeting in Orlando.

The National Institutes of Health is running a large study to find out if screening patients with CT scans can save lives. Some doctors are already offering the screenings in the hopes of finding tumors early, when they might be more curable. Lung cancer kills more people than any other tumor, with 215,000 new cases a year and 162,000 deaths, according to the American Cancer Society.

But the scan's results aren't always clear or easy to interpret, leading to false alarms.
People who are screened have a 21% chance of being unnecessarily frightened by findings that initially seem suspicious, but turn out to be benign, says lead author Jennifer Croswell.

Yet the exams, performed with CT scans, can produce more than just anxiety, according to Croswell's report, a pilot study for the ongoing National Lung Screening Trial, which includes 50,000 patients.

Suspicious findings can lead to invasive follow-up exams, such as biopsies or even surgeries in which doctors crack open the chest to access to the lungs, Croswell says.

Out of 1,600 smokers and ex-smokers in the study who had the CT scans, 40 had real cancer, but eight had unnecessary surgery for non-cancerous conditions.

Yet Croswell can't say whether the screenings actually helped anyone. That's because the larger study hasn't gone on long enough to show whether screening saves lives, she says. And because lung surgeries are risky, she says it's possible for the screenings themselves to cause death.

CT scans also expose people to radiation, which increases the risk of cancer, says Peter Bach, a pulmonologist at New York's Memorial Sloan-Kettering Cancer Center.

Other research has suggested that tumors found through screening could be much less lethal than lung cancers that are found because they cause symptoms, so that finding these slow-growing cancers may not help anyone. Also, longtime smokers or ex-smokers could die of other causes, such as heart attacks or strokes, long before their cancer becomes a threat.

In fact, people who get CT scans are 100 times more likely to get a false alarm then they are to die of lung cancer, says Bach, the author of a 2007 study on lung cancer screening.

The American Cancer Society does not recommend lung screenings and they are not covered by insurance, Bach says. Insurers do cover follow-up tests and lung cancer treatments.

Go here to see what other readers think.

Monday, June 1, 2009

Science Daily reports: Drug Combination Improves Outcome For Advanced Non-small Cell Lung Cancer

A new, international study found that the combination of two drugs delays disease progression for patients with advanced non-small cell lung cancer (NSCLC). Results from the Phase III "ATLAS" trial were presented May 30 by Dr. Vincent Miller of Memorial Sloan-Kettering Cancer Center (MSKCC) at the American Society of Clinical Oncology Annual Meeting.

The goal of the study was to determine whether adding erlotinib (Tarceva®), a targeted agent, to maintenance therapy with bevacizumab (Avastin®), an agent commonly used as a component of treatment for advanced NSCLC would delay disease progression. Maintenance therapy involves using one or more agents of a chemotherapy regimen, but not the entire regimen, to delay disease progression and possibly improve survival after patients have previously received stronger standard chemotherapy, which can have significant side effects.

"This is the first study to show the addition of erlotinib to maintenance therapy prolongs progression-free survival in patients with advanced non-small cell lung cancer," said Dr. Miller, a thoracic oncologist at MSKCC and one of the study's lead authors. "Knowing which patients will get the greatest benefit from this combination, based on the identification of biomarkers, will be an important next step in this research," Dr. Miller added.

Read more.


Science Daily reports: Activated Stem Cells In Damaged Lungs Could Be First Step Toward Cancer

Stem cells that respond after a severe injury in the lungs of mice may be a source of rapidly dividing cells that lead to lung cancer, according to a team of American and British researchers.

"There are chemically resistant, local-tissue stem cells in the lung that only activate after severe injury," said Barry R. Stripp, Ph.D., professor of medicine and cell biology at Duke University Medical Center. "Cigarette smoke contains a host of toxic chemicals, and smoking is one factor that we anticipate would stimulate these stem cells. Our findings demonstrate that, with severe injury, the resulting repair response leads to large numbers of proliferating cells that are derived from these rare stem cells."

Stripp said this finding could be related to the increased incidence of lung cancer in people with chronic disease states, in particular among cigarette smokers.

The findings were published in the advance online edition of the Proceedings of the National Academy of Sciences during the week of May 25.

Read more.


Suggested Blogs

Kick Butts Today!